Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report)’s share price passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $0.28 and traded as low as $0.28. Northwest Biotherapeutics shares last traded at $0.28, with a volume of 2,596,458 shares traded.
Northwest Biotherapeutics Price Performance
The company has a fifty day simple moving average of $0.28 and a two-hundred day simple moving average of $0.32. The company has a market capitalization of $377.00 million, a P/E ratio of -3.56 and a beta of -0.50.
About Northwest Biotherapeutics
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
See Also
- Five stocks we like better than Northwest Biotherapeutics
- How Can Investors Benefit From After-Hours Trading
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- How to Capture the Benefits of Dividend Increases
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
